Literature DB >> 10064889

Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain.

T M Hansen1, H Nielsen, N Bernth, T Moos.   

Abstract

In non-neuronal tissue, ferritin subunit mRNAs are regulated by post-transcriptional mechanisms leading to decreased ferritin protein synthesis during iron deficiency. Biochemical studies have demonstrated that the cerebral ferritin concentration declines during iron deficiency, suggesting that expression of ferritin subunit mRNAs in the brain may be regulated by mechanisms similar to those of non-neuronal tissue. However, as ferritin expression has been only vaguely studied in brain, this hypothesis remains to be tested. We investigated the influence of dietary iron deficiency on the cellular distribution of ferritin protein using immunohistochemistry and H- and L-ferritin subunit mRNAs by non-radioactive in situ hybridization. Pregnant rats were subjected to an iron depleted diet (6.4 mg/kg) from the day of conception. Litters were kept on the same diet until euthanized at the postnatal age of 10 weeks. This treatment reduced brain iron levels from approximately 57 to 26 microgram/g. Reducing the iron stores reduced histochemical detectable iron and the expression of ferritin immunoreactivity in neurons, oligodendrocyte-like and microglia-like cells. In normal rats, H- and L-ferritin subunit mRNAs were expressed in virtually all neurons and non-neuronal cells. The cerebral expression of the ferritin subunit mRNAs was not affected by iron deficiency. The levels of ferritin subunit mRNAs in the brain were also unaltered from iron deficiency when examined by Northern blotting. In conclusion, brain levels of iron and ferritin protein are highly susceptible to dietary iron deficiency, whereas the cerebral expression of H- and L-ferritin subunit mRNAs remains unchanged. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064889     DOI: 10.1016/s0169-328x(99)00011-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  10 in total

1.  Apotransferrin protects cortical neurons from hemoglobin toxicity.

Authors:  Jing Chen-Roetling; Lifen Chen; Raymond F Regan
Journal:  Neuropharmacology       Date:  2010-10-27       Impact factor: 5.250

Review 2.  Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus.

Authors:  M B H Youdim
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

Review 3.  The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.

Authors:  Laura Mahoney-Sanchez; Abdel Ali Belaidi; Ashley I Bush; Scott Ayton
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

4.  Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

Authors:  David E Connor; Ganta V Chaitanya; Prashant Chittiboina; Paul McCarthy; L Keith Scott; Lisa Schrott; Alireza Minagar; Anil Nanda; J Steven Alexander
Journal:  Pathophysiology       Date:  2017-05-13

5.  Neurons lacking iron regulatory protein-2 are highly resistant to the toxicity of hemoglobin.

Authors:  Raymond F Regan; Mai Chen; Zhi Li; Xuefeng Zhang; Luna Benvenisti-Zarom; Jing Chen-Roetling
Journal:  Neurobiol Dis       Date:  2008-05-03       Impact factor: 5.996

Review 6.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

7.  Iron is Responsible for Production of Reactive Oxygen Species Regulating Vasopressin Expression in the Mouse Paraventricular Nucleus.

Authors:  Jong-A Hyeun; Ji Young Kim; Chan Hyung Kim; Jin-Hee Kim; Eun Young Lee; Je Hoon Seo
Journal:  Neurochem Res       Date:  2019-03-04       Impact factor: 3.996

8.  Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders.

Authors:  Tina Skjørringe; Lisbeth Birk Møller; Torben Moos
Journal:  Front Pharmacol       Date:  2012-09-25       Impact factor: 5.810

9.  Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.

Authors:  Scott Ayton; Noel G Faux; Ashley I Bush
Journal:  Nat Commun       Date:  2015-05-19       Impact factor: 14.919

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.